BioSpace News Archive

Policy

FDA Panel Votes 8-7 in Favor of Mallinckrodt’s HRS-1 Drug

Shares of Mallinckrodt climbed after the company announced the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration voted to recommend approval for its investigational agent terlipressin to treat adults with hepatorenal syndrome type 1.

July 16, 2020
·
2 min read
·
Alex Keown
Canine Arthritis Treatment Market Growth is Attributed to Increased Cases of Arthritis in Pets

The global canine arthritis treatment market is expected to weave a strong web of growth during the forecast period of 2019 to 2029.

July 16, 2020
·
3 min read
Deals

Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million

Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced that it has successfully completed a CHF 7.5 million Series B equity financing round.

July 16, 2020
·
2 min read
Drug Development

IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial

4 evaluable GNAQ/11 mutation skin melanoma patients enrolled in Stage 1 cohort with a 100% Disease Control Rate (excluding 1 non-evaluable) and 1 confirmed partial response by RECIST 1.1 guidelines

July 16, 2020
·
4 min read
MolecuLight Launches the i:X® Telemedicine Solution for Imaging of Bacteria in Wounds

New Telemedicine Solution allows the MolecuLight i:X Device to be used at the Bedside for Synchronous Interpretation of the Images by Remote Wound Care Clinicians

July 16, 2020
·
3 min read
BioMidwest

Walgreens Earns Best Place to Work on 2020 Disability Equality Index

National Recognition Spotlights Walgreens Training and Job Readiness Programs for People with Disabilities

July 16, 2020
·
4 min read
Deals

BIOLASE Announces Expiration Of Oversubscribed Rights Offering

BIOLASE, Inc., a global leader in dental lasers, announced the expiration of the Company’s rights offering, which was oversubscribed.

July 16, 2020
·
5 min read
Drug Development

New Preclinical Study Finds Niagen® Corrects Social Deficits in Mouse Model of Autism

First-of-its-kind preclinical study shows that Niagen® resolves social deficits and anxiety-like behaviors in male mice

July 16, 2020
·
6 min read
Business

Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020

Alexion Pharmaceuticals, Inc. announced that the Company will report its financial results for the second quarter ended June 30, 2020 before the US financial markets open on July 30, 2020.

July 16, 2020
·
1 min read
Business

Johnson & Johnson Reports 2020 Second-Quarter Results:

Sales of $18.3 billion reflecting a decline of 10.8%, operational decline of 9.0%* and adjusted operational decline of 8.8%*, primarily driven by the negative impact of the COVID-19 pandemic

July 16, 2020
·
13 min read